Regular insulin explained

Tradename:Humulin R, Novolin R, Actrapid, others[1]
Dailymedid:Humulin
Routes Of Administration:Subcutaneous, intramuscular, intravenous
Atc Prefix:A10
Atc Suffix:AB
Biosimilars:Myxredlin
Legal Ca:Rx-only
Legal Ca Comment:/Schedule D[2]
Legal Us:OTC
Legal Us Comment:/ Rx-only[3]
Onset:30 minutes
Duration Of Action:8 hours
Cas Number:9004-10-8
Cas Supplemental:
(insulin human)
Chemspiderid:none
Unii:1Y17CTI5SR
Synonyms:insulin injection (soluble), neutral insulin, regular human insulin, human insulin (regular), Toronto insulin

Regular insulin, also known as neutral insulin and soluble insulin, is a type of short-acting medical insulin. It is used to treat type 1 diabetes, type 2 diabetes, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states.[4] It is also used along with glucose to treat high blood potassium levels.[5] Typically it is given by injection under the skin, but may also be used by injection into a vein or muscle. Onset of effect is typically in 30 minutes and it typically lasts for 8 hours.[4]

The common side effect is low blood sugar.[4] Other side effects may include pain or skin changes at the sites of injection, low blood potassium, and allergic reactions.[4] Use during pregnancy is relatively safe for the baby.[4] Regular insulin can be made from the pancreas of pigs or cows. Human versions can be made either by modifying pig versions or recombinant technology.[6]

Insulin was first used as a medication in Canada by Charles Best and Frederick Banting in 1922.[7] It is on the World Health Organization's List of Essential Medicines.[8] In 2017, it was the 209th most commonly prescribed medication in the United States, with more than 2million prescriptions.[9] Versions are also available mixed with longer-acting versions of insulin, such as NPH insulin.[6] In 2020, the combination of human insulin with insulin isophane was the 246th most commonly prescribed medication in the United States, with more than 2million prescriptions.[10] [11]

Medical uses

Regular insulin is used for the long-term management of diabetes.[4] It is the treatment of choice for the two diabetic emergencies diabetic ketoacidosis and hyperosmolar hyperglycemic states.[4] It may also be used in combination with glucose to lower potassium levels in those with hyperkalemia.[5]

Side effects

Side effects may include: low blood sugar levels, skin reactions at the site of injection and low potassium levels among others.[4]

Manufacture

Humulin, one brand name for a group of biosynthetic human insulin products, is synthesized in a laboratory strain of Escherichia coli bacteria which has been genetically altered with recombinant DNA to produce biosynthetic human insulin. Humulin R consists of zinc-insulin crystals dissolved in a clear fluid.

Formulations

It is sold by many manufacturers in a number of different forms.

By Eli Lilly these include:

In UK these include:[12]

Notes and References

  1. Web site: insulin regular human (OTC) – Humulin R, Novolin R. 1 December 2014. live. https://web.archive.org/web/20141216210952/http://reference.medscape.com/drug/humulin-r-novolin-r-insulin-regular-human-999007. 16 December 2014.
  2. Web site: Summary Basis of Decision - Myxredlin . Health Canada . 23 October 2014 . 23 February 2023.
  3. Web site: Humulin R U-500- insulin human injection, solution Humulin R U-500 Kwikpen- insulin human injection, solution . DailyMed . 27 June 2022 . 23 February 2023.
  4. Web site: American Society of Health-System Pharmacists. Insulin Human. drugs.com. 1 January 2017. live. https://web.archive.org/web/20161022221822/https://www.drugs.com/monograph/insulin-human.html. 22 October 2016.
  5. Mahoney BA, Smith WA, Lo DS, Tsoi K, Tonelli M, Clase CM . Emergency interventions for hyperkalaemia . The Cochrane Database of Systematic Reviews . 2005 . 2 . CD003235 . April 2005 . 15846652 . 6457842 . 10.1002/14651858.CD003235.pub2 .
  6. Book: British national formulary : BNF 69. 2015. British Medical Association. 9780857111562. 464472. 69th.
  7. Book: Fleishman JL, Kohler JS, Schindler S . Casebook for The Foundation a Great American Secret. . 2009 . PublicAffairs . New York . 978-0-7867-3425-2 . 22 . live . https://web.archive.org/web/20170118063518/https://books.google.com/books?id=5RmHA1SAoAgC&pg=PA22 . 18 January 2017.
  8. Book: ((World Health Organization)) . World Health Organization model list of essential medicines: 21st list 2019 . 2019 . 10665/325771 . World Health Organization . World Health Organization . Geneva . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO . free .
  9. Web site: Insulin Human - Drug Usage Statistics . ClinCalc . 11 April 2020.
  10. Web site: The Top 300 of 2020 . ClinCalc . 7 October 2022.
  11. Web site: Insulin Human; Insulin Isophane Human - Drug Usage Statistics . ClinCalc . 7 October 2022.
  12. News: Human Insulin - Types, Production, Action, History. 17 November 2017.